Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular events in chronic myeloid leukemia progression.
Guerrasio A, Serra A, Gottardi E, Cilloni D, Vischia F, Parvis G, Cilli V, Saglio G. Guerrasio A, et al. Among authors: parvis g. Leukemia. 1997 Apr;11 Suppl 3:519-21. Leukemia. 1997. PMID: 9209443
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.
Carrà G, Panuzzo C, Torti D, Parvis G, Crivellaro S, Familiari U, Volante M, Morena D, Lingua MF, Brancaccio M, Guerrasio A, Pandolfi PP, Saglio G, Taulli R, Morotti A. Carrà G, et al. Among authors: parvis g. Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348. Oncotarget. 2017. PMID: 28418900 Free PMC article.
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.
Morotti A, Parvis G, Cilloni D, Familiari U, Pautasso M, Bosa M, Messa F, Arruga F, Defilippi I, Catalano R, Rosso V, Carturan S, Bracco E, Guerrasio A, Saglio G. Morotti A, et al. Among authors: parvis g. Leukemia. 2007 Jun;21(6):1305-6. doi: 10.1038/sj.leu.2404581. Epub 2007 Mar 22. Leukemia. 2007. PMID: 17377595 No abstract available.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U; Fondazione Italiana Linfomi. Ladetto M, et al. Blood. 2013 Nov 28;122(23):3759-66. doi: 10.1182/blood-2013-06-507319. Epub 2013 Oct 1. Blood. 2013. PMID: 24085766 Free article. Clinical Trial.
Distribution of TP53 mutations among acute leukemias with MLL rearrangements.
Lanza C, Gaidano G, Cimino G, Pastore C, Nomdedeu J, Volpe G, Vivenza C, Parvis G, Mazza U, Basso G, Madon E, Lo Coco F, Saglio G. Lanza C, et al. Among authors: parvis g. Genes Chromosomes Cancer. 1996 Jan;15(1):48-53. doi: 10.1002/(SICI)1098-2264(199601)15:1<48::AID-GCC7>3.0.CO;2-4. Genes Chromosomes Cancer. 1996. PMID: 8824725
35 results